This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Andrzej Gondela: Innovator in Medical Chemistry
Introduction
Andrzej Gondela is a notable inventor based in Tychy, Poland. He has made significant contributions to the field of medical chemistry, particularly through his innovative work on disubstituted alkyne derivatives. His research focuses on developing compounds that can aid in the prevention and treatment of various medical conditions.
Latest Patents
Gondela holds 1 patent for his invention related to disubstituted alkyne derivatives. This patent outlines the utility of these compounds in addressing hyperproliferative disorders and diseases, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Andrzej Gondela has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merck Patent GmbH and Ryvu Therapeutics S.A. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.
Collaborations
Gondela has collaborated with esteemed colleagues, including Timo Heinrich and Michal Galezowski. These partnerships have further enriched his research endeavors and have played a crucial role in the development of his patented inventions.
Conclusion
Andrzej Gondela's work exemplifies the intersection of innovation and medical research. His contributions to the field through his patent on disubstituted alkyne derivatives highlight his dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile